Napo Pharmaceuticals, Inc.’s Post

Issuance of New European & Australian Patents to Jaguar Health Family Company Napo Pharmaceuticals Bolster IP Protection in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)

Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs) | Jaguar Health, Inc.

Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs) | Jaguar Health, Inc.

jaguarhealth.gcs-web.com

To view or add a comment, sign in

Explore topics